PT3463332T - Dgla na profilaxia de doença alérgica - Google Patents

Dgla na profilaxia de doença alérgica

Info

Publication number
PT3463332T
PT3463332T PT177111093T PT17711109T PT3463332T PT 3463332 T PT3463332 T PT 3463332T PT 177111093 T PT177111093 T PT 177111093T PT 17711109 T PT17711109 T PT 17711109T PT 3463332 T PT3463332 T PT 3463332T
Authority
PT
Portugal
Prior art keywords
prophylaxis
composition
allergic disease
allergic
disease
Prior art date
Application number
PT177111093T
Other languages
English (en)
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of PT3463332T publication Critical patent/PT3463332T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
PT177111093T 2016-06-01 2017-03-10 Dgla na profilaxia de doença alérgica PT3463332T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16172431 2016-06-01

Publications (1)

Publication Number Publication Date
PT3463332T true PT3463332T (pt) 2021-06-30

Family

ID=56108531

Family Applications (1)

Application Number Title Priority Date Filing Date
PT177111093T PT3463332T (pt) 2016-06-01 2017-03-10 Dgla na profilaxia de doença alérgica

Country Status (12)

Country Link
EP (1) EP3463332B1 (pt)
CN (1) CN109152759A (pt)
AR (1) AR107869A1 (pt)
BR (1) BR112018073060A2 (pt)
CA (1) CA3024191A1 (pt)
ES (1) ES2877810T3 (pt)
MX (1) MX2018014140A (pt)
PH (1) PH12018502252A1 (pt)
PT (1) PT3463332T (pt)
SG (1) SG11201809177UA (pt)
TW (1) TWI803459B (pt)
WO (1) WO2017207124A1 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591446A (en) * 1989-04-04 1997-01-07 Beiersdorf, A.G. Methods and agents for the prophylaxis of atopy
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
GB9217781D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
GB9510636D0 (en) * 1995-05-25 1995-07-19 Scotia Holdings Plc Fatty acid treatment
US20040076695A1 (en) * 2002-07-08 2004-04-22 Advanced Vision Research EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia
JP5546087B2 (ja) * 2005-02-14 2014-07-09 サントリーホールディングス株式会社 皮膚疾患経口治療または予防剤

Also Published As

Publication number Publication date
PH12018502252A1 (en) 2019-08-19
TWI803459B (zh) 2023-06-01
CA3024191A1 (en) 2017-12-07
CN109152759A (zh) 2019-01-04
SG11201809177UA (en) 2018-12-28
TW201742624A (zh) 2017-12-16
MX2018014140A (es) 2019-02-25
EP3463332B1 (en) 2021-04-21
EP3463332A1 (en) 2019-04-10
BR112018073060A2 (pt) 2019-04-09
ES2877810T3 (es) 2021-11-17
WO2017207124A1 (en) 2017-12-07
AR107869A1 (es) 2018-06-13

Similar Documents

Publication Publication Date Title
IL252477A0 (en) 2-aminopyrimidine compound, pharmaceutical structure and its use
LT3426226T (lt) Oftalmologinė kompozicija
IL251351B (en) Preparations for use in the treatment and prevention of surgical infections
EP3117827A4 (en) Composition for vagina and use of the composition
EP3479835A4 (en) COMPOSITION FOR USE IN IMPROVING THE NUTRITIONAL STATE
PT3160464T (pt) 6-hidroxibuspirona para uso no tratamento de transtornos do movimento
RS62465B1 (sr) Imatinib za upotrebu u lečenju moždanog udara
HK1225994A1 (zh) 用於治療過敏性病症的組合物
GB2552400B (en) Personal cleansing composition
IL251345B (en) Preparations for use in the treatment of peri-implantitis
GB201614961D0 (en) Compounds and compositions for use
SI3349594T1 (sl) Sestavek nadomestka soli in uporaba le-tega
GB2569682B (en) Topical composition for use in the treatment of burns
GB2581876B (en) Compositions for use in the treatment of endometrial disorder
PL3548006T3 (pl) Kompozycja do stosowania w leczeniu zmian jelitowych
PT3463332T (pt) Dgla na profilaxia de doença alérgica
PL3020794T3 (pl) Kompozycja środka piorącego i jej zastosowanie
GB201513543D0 (en) Compositions for use in the treatment of diabetes
SG11201706369PA (en) Compositions and methods for the treatment of mucositis
GB201621959D0 (en) Compositions and their use
GB201603510D0 (en) Compositions for use in the treatment of neurological disease
GB201621390D0 (en) Novel compositions having use in therapy
GB201602665D0 (en) Compositions and their use
PL3273997T3 (pl) Kompozycja do leczenia nieżytu nosa
HUP1600286A2 (en) Fungicidal composition and its use